TRYNGOLZA
Active substance: olezarsen
INJECTION, SOLUTION · OLEZARSEN SODIUM 50 mg/.8mL
United StatesActive
Marketing holder: Ionis Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- OLEZARSEN SODIUM · 50 mg/.8mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12092-9c41-7406-b476-d9c73165eb53,01a12095-0fca-7b9d-81bc-a0430ce89192;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71860-102
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 71860-102 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71860-102 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71860-102 · Verified 2026-10-09 · open in source